Pharmaceuticals in Japan
Summary
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Japanese pharmaceuticals market registered revenue of $94.3 billion in 2023, representing a compound annual growth rate (CAGR) of 7.3% between 2018 and 2023.
- Japan captured a share of 24.1% in the Asia-Pacific pharmaceuticals market, in 2023.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
- What was the size of the Japan pharmaceuticals market by value in 2023?
- What will be the size of the Japan pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Japan’s pharmaceuticals market in relation to its regional counterparts?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Otsuka Holdings Co Ltd
- 8.2. Astellas Pharma Inc
- 8.3. Takeda Pharmaceutical Co Ltd
- 8.4. Daiichi Sankyo Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Japan pharmaceuticals market value: $ billion, 2018-23
- Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Japan pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Otsuka Holdings Co Ltd: Key Facts
- Table 5: Otsuka Holdings Co Ltd: Annual Financial Ratios
- Table 6: Otsuka Holdings Co Ltd: Key Employees
- Table 7: Otsuka Holdings Co Ltd: Key Employees Continued
- Table 8: Astellas Pharma Inc: Key Facts
- Table 9: Astellas Pharma Inc: Annual Financial Ratios
- Table 10: Astellas Pharma Inc: Key Employees
- Table 11: Takeda Pharmaceutical Co Ltd: Key Facts
- Table 12: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 13: Takeda Pharmaceutical Co Ltd: Key Employees
- Table 14: Takeda Pharmaceutical Co Ltd: Key Employees Continued
- Table 15: Daiichi Sankyo Co Ltd: Key Facts
- Table 16: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 17: Daiichi Sankyo Co Ltd: Key Employees
- Table 18: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 20: Japan Size of Population (million), 2019-23
- Table 21: Japan Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 22: Japan GDP (current prices, $ billion), 2019-23
- Table 23: Japan Inflation, 2019-23
- Table 24: Japan Consumer Price Index (absolute), 2019-23
- Table 25: Japan Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook